|
Patients
with life-threatening diseases often lose their appetite and
may lose weight. When severe, this is called cachexia
or wasting syndrome.
 |
Inadequate
intake of nutrients because the patient cannot or does
not want to eat |
 |
Poor
absorption of food that is consumed |
 |
Changes
in the patient's metabolism |
 |
Eating
small, frequent meals |
 |
Eating
high-calorie, high-protein foods and nutritional supplements
|
 |
Receiving
nutritional counseling |
 |
Feeding
through artificial means (such as a tube or IV) |
 |
Eating
and drinking whatever the patient would like |
 |
Relieving
thirst by sucking on ice chips or a moist cloth |
 |
Corticosteroids,
which stimulate appetite but do not usually increase weight |
 |
Megestrol
acetate, which stimulates appetite and causes slight weight
gain |
 |
Dronabinol,
which prevents nausea and vomiting, and increases appetite,
enhances a sense of well-being and causes weight-gain
|
 |
Cyproheptadine,
which mildly enhances appetite, increases food intake
and enhances weight gain |
 |
Pentoxifylline,
which potentially acts to lower levels of a substance
(tumor necrosis factor) that contributes to weight loss
in cancer patients. |
|
|